Skip to main content
Caplight Logo









Myllia Biotechnology

Myllia Biotechnology

Private
ViennaHealthcare & Life Scienceshttps://myllia.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Myllia Biotechnology is a biotechnology company that specializes in functional genomics by combining CRISPR-based perturbations with single-cell RNA sequencing to accelerate drug target discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Synthetic Data, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

functional genomicsCRISPR screeningCROP-seqsingle-cell sequencingdrug target discoveryoptical pooled screeningOPScontract research organizationCROAI-ready datasynthetic biology datadrug discovery platformbiological databiotech datain silico drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myllia Biotechnology Comparables

Compare Myllia Biotechnology with similar companies based on industry and business-model similarity.

Myllia Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Algen Biotechnologies
86%
Scenic Biotech
84%
Engine Biosciences
82%

Myllia Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Tilmann Burckstummer

Founder and Chief Scientific Officer

Founding Team

Thomas Moser

Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 30% MoM, reaching 4.9K.

  • Mar 2, 2026

    Monthly visitors grew 72% MoM, reaching 19.4K.

Myllia Biotechnology Filings

Explore SEC and related filing metadata, where available.

Myllia Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Myllia Biotechnology's valuation, stock price, and market status.

Is Myllia Biotechnology a public or private company?

Myllia Biotechnology is a private company.

What is the current stock price of Myllia Biotechnology?

Myllia Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Myllia Biotechnology worth (valuation)?

Valuation information for Myllia Biotechnology is not publicly available.

Can I buy Myllia Biotechnology stock?

Myllia Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Myllia Biotechnology's last funding round?

Funding round information for Myllia Biotechnology is not publicly available.

Who are the main investors in Myllia Biotechnology?

Investor information for Myllia Biotechnology is not publicly disclosed.

Will Myllia Biotechnology IPO soon?

No public IPO plans have been announced for Myllia Biotechnology.

How can I track Myllia Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myllia Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range18
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?